Playbook: How the pharmaceutical industry can benefit from the post-pandemic boom

Experts predict that technological breakthroughs, macroeconomic changes, and opportunities arising from generational demand will generate a post-pandemic boom worldwide, especially in the United States. The outlook for the future is positive. A decade ago, the pharmaceutical industry experienced significant consequences as one of the sectors most affected by budget cuts, resulting in restructuring business models and market supply.

While organizations find meaningful ways to leverage volumes of data, bad or poor-quality data create hindrances. Staying organized and keeping data healthy and running is critical to the pharmaceutical business. Duplicate, outdated, inaccurate, incomplete, or inconsistent data can significantly impact efforts to grow profitably...